Vidac Pharma’s Dr. Max Herzberg, Management Board member, sells shares for EUR 430
Reuters2026/09/10 18:01- Vidac Pharma Holding board member Dr. Max Herzberg sold shares on Sept. 7, 2026.
- Transaction priced at EUR 0.43 per share for a total value of EUR 430.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mentor Walsh and legendary trader Druckenmiller closed-door meeting: US interest rates are too low, dovish stance is absurd, AI may have a profit bubble
Druckenmiller, who was a long-term mentor to former U.S. Treasury Secretary Paul Volcker and Federal Reserve Chairman Alan Greenspan, stated that there is "no longer a need" for the Federal Reserve to cut interest rates. He characterized the recent sustained increase in yields as "a slow, fundamentally driven rise." Regarding AI, he commented: "We are likely in a profit bubble, as this AI craze will eventually come to an end," and revealed that he has reduced his AI-related holdings to 20% of what they were six months ago.
XRP ETFs stay positive again with $12.29M as BTC funds rack up outflows
Foraco founder Daniel Simoncini cuts stake to 8.64% after selling 2 million shares
Western Pacific Trust declares annual dividend of $0.005 per share